Skip to main content

Patient Search

Testimonials Testimonials

Displaying 1 - 10 of 29

Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101

Hematologic

Subjects are enrolled in this study following completion or early discontinuation from a Poseida sponsored or supported study of P-BCMA-101 T cells and will be followed for a total of 15 years post treatment from the last P-BCMA-101 treatment. Subjects will be monitored for safety and efficacy to assess the risk of delayed adverse events (AEs) and assess long-term efficacy, and PK and quantification of P-BCMA-101 T cells. Rimiducid may be administered as indicated.
Hematologic
I
Dholaria, Bhagirathbhai
NCT03741127
VICCCTT20114

Hematologic Malignancy Tumor Bank

Multiple Cancer Types

Hematologic, Leukemia, Lymphoma
N/A
Seegmiller, Adam
VICCHEM1217

Optimization of Cancer Therapy Using Immune Effector Cells

Hematologic

Hematologic
N/A
Oluwole, Olalekan
VICCCTT1834

A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)

Hematologic

Hematologic
N/A
Wheeler, Allison
VICCNCBH19121

von Willebrand Factor in Pregnancy (VIP) Study: A Multicenter Study of Wilate Use in von Willebrand Disease for Childbirth

Hematologic

Hematologic
N/A
Wheeler, Allison
VICCNCBH2005

Prospective Validation of a Venous Thrombosis Risk Assessment Model in Critically Ill Children from the CHAT Registry

Hematologic

Hematologic
N/A
Wheeler, Allison
VICCNCBH2010

Discovering Outcomes in Clonal Hematopoiesis: The Clonal Hematopoiesis and Inflammation in VasculaturE (CHIVE) Registry and Biorepository

Hematologic

Hematologic
N/A
Savona, Michael
VICCHEM20123

NN7999-3895: Safety and Efficacy of nonacog beta pegol (N9-GP) in Previously Untreated Patients with Haemophilia B

Hematologic

Hematologic
III
Wheeler, Allison
NCT02141074
VICCNCBH1756

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Hematologic

Hematologic
N/A
Kassim, Adetola
NCT04920474
NMDPCTT0346

Prospective, Randomized, Crossover Trial Comparing Recombinant von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women with von Willebrand Disease: The VWD Minimize Study

Multiple Cancer Types

Gynecologic, Hematologic
III
Wheeler, Allison
NCT02606045
VICCNCBH1961